Marksans Pharma's stock surges 12% after deal with Tevapharm India

Shares of Marksans Pharma surged by nearly 12% on Wednesday after it announced a plan for a business transfer agreement with Tevapharm India Private Limited. Marksans will acquire Tevapharm's manufacturing and supply of bulk pharmaceutical formulations business in Goa on a slump sale basis. At 2:50 pm, Marksans Pharma's stock was trading 5.68% higher at ₹49.30 apiece on the BSE.